Epidemiological Characteristics from 2008 to 2018 and Trend Prediction of Pulmonary Tuberculosis in Yinchuan City

doi:10.12114/j.issn.1007-9572.2019.00.556

Abstract

Abstract: Background　Pulmonary tuberculosis（TB） is a public health issue of global concern.Yinchuan is one of the cities with relatively poor economic development in Northwest China in which the prevention and control of TB started late.Objective　To analyze the epidemiological characteristics of pulmonary TB in Yinchuan from 2008 to 2018，and to predict the incidence trend，providing a scientific basis for the prevention and control of this disease.Methods　Descriptive epidemiologic methods and estimated annual percentage change（EAPC） were used for analyzing the surveillance data of pulmonary TB in Yinchuan from 2008 to 2018，and autoregressive integrated moving average model（ARIMA） was used to predict the incidence trend from January 2019 to June 2020．Results　A total of 9 518 cases were reported in Yinchuan from 2008 to 2018.The annual incidence in this period showed a downward trend generally，and the average annual incidence was 42.71/100 000.The male-to-female incidence ratio was 1.39∶1，and the male incidence was significantly higher than that of females（49.34/100 000 vs 35.56/100 000，χ2=25.86，P<0.001）．Pulmonary TB occurred in all age groups，with the highest incidence among the elderly aged 60 and over（119.47/100 000）．Main populations of the TB were farmers 〔40.01%（3 808/9 518）〕.Yongning County had the highest average annual incidence（61.98/100 000），and Lingwu City had the lowest（34.81/100 000）．Most cases occurred in March and April.ARIMA model prediction results showed that the incidence of pulmonary TB in Yinchuan from January 2019 to June 2020 would be lower than that in 2018，showing a downward trend.Conclusion　The incidence of TB in Yinchuan City showed a downward trend from 2008 to 2018.Farmers are key populations in pulmonary TB prevention and control，and attentions should also be paid to the elderly.

Key words: Tuberculosis, Incidence, Epidemiologic methods, Data collection, Forecasting, Yinchuan

摘要： 背景　肺结核是全球关注的公共卫生问题。银川市是西北经济发展较为落后的城市之一，结核病的防治工作起步较晚。目的　分析2008—2018年银川市肺结核的流行特征，并预测发病趋势，为肺结核的防控提供科学依据。方法　采用描述性流行病学方法和年估计百分比变化（EAPC）对2008—2018年银川市肺结核监测数据进行分析，采用自回归移动平均混合模型（ARIMA）预测2019年1月—2020年6月肺结核的发病趋势。结果　2008—2018年银川市共报告肺结核9 518例，年均发病率为42.71/10万，整体呈下降趋势。男女发病率比为1.39∶1，男性肺结核发病率高于女性（49.34/10万与35.56/10万，χ2=25.86，P<0.001）；各年龄组均有病例发生，60岁及以上老年人发病率最高（119.47/10万）；发病职业以农民为主〔40.01%（3 808/9 518）〕。永宁县发病率最高（61.98/10万），灵武市最低（34.81/10万）。3、4月发病例数最多。ARIMA预测发现2019年1月—2020年6月银川市肺结核发病水平低于2018年，呈下降趋势。结论　2008—2018年银川市肺结核发病率呈整体下降趋势，农民是银川市肺结核防治工作重点，此外，应关注老年人的发病情况。

关键词: 肺结核, 发病率, 流行病学方法, 数据收集, 预测, 银川

LIU Xiaojuan,LI Yan,SHA Xiaolan, et al. Epidemiological Characteristics from 2008 to 2018 and Trend Prediction of Pulmonary Tuberculosis in Yinchuan City　[J]. Chinese General Practice, 2019, 22(32): 3975-3979. DOI: 10.12114/j.issn.1007-9572.2019.00.556.
刘小娟,李燕,沙小兰等. 2008—2018年银川市肺结核流行特征调查分析及趋势预测[J]. 中国全科医学, 2019, 22(32): 3975-3979. DOI: 10.12114/j.issn.1007-9572.2019.00.556.

References

［1］CHANDRA S，SHARMA N，JOSHI K，et al．Resurrecting social infrastructure as a determinant of urban tuberculosis control in Delhi，India［J］．Health Res Policy Syst，2014，12：3．DOI：10.1186/1478-4505-12-3.
［2］Organization World Health.Global tuberculosis report 2017［R/OL］．Geneva：WHO，2017.
［3］毛强．2004—2015年全国肺结核流行趋势时空特征及预测研究［D］．兰州：兰州大学，2018.
［4］夏愔愔，杜昕，陈伟，等．2010年全国肺结核患病率地区差异分析［J］．中国防痨杂志，2012，34（12）：803-807.
XIA Y Y，DU X，CHEN W，et al．Pulmonary tuberculosis prevalence among different regions in China in 2010［J］．Chinese Journal of Antituberculosis，2012，34（12）：803-807.
［5］邹级谦.肺结核诊断标准［J］．结核病健康教育，2008（1）：7-9.
［6］STANG A，J?CKEL K H，HEIDINGER O.Skin cancer rates in North Rhine-Westphalia，Germany before and after the introduction of the nationwide skin cancer screening program（2000—2015）［J］．Eur J Epidemiol，2018，33（3）：303-312．DOI：10.1007/s10654-017-0348-6.
［7］张懿行，李小攀，孙乔，等．2008—2014年上海市浦东新区居民肺结核发病情况及其趋势分析［J］．疾病监测，2016，31（1）：29-33．DOI：10.3784/j.issn.1003-9961.2016.01.008.
ZHANG Y X，LI X P，SHUN Q，et al．Incidence of tuberculosis in residents in Pudong New District of Shanghai，2008—2014［J］.Disease Surveillance，2016，31（1）：29-33．DOI：10.3784/j.issn.1003-9961.2016.01.008.
［8］全国第五次结核病流行病学抽样调查技术指导组，全国第五次结核病流行病学抽样调查办公室．2010年全国第五次结核病流行病学抽样调查报告［J］．中国防痨杂志，2012，34（8）：485-508.
Technical Guidance Group of the Fifth National TB Epidemiological Survey，the Office of the Fifth National TB Epidemiological Survey.The fifth national tuberculosis epidemiological survey in 2010［J］．Chinese Journal of Antituberculosis，2012，34（8）：485-508.
［9］上官致洋，谢彬艳，朱小康，等．2011—2016年抚州市肺结核流行病学特征分析［J］．现代预防医学，2018，45（4）：600-602，608.
SHANGGUAN Z Y，XIE B Y，ZHU X K，et al．Analysis on the epidemiological characteristics of tuberculosis in Fuzhou City from 2011—2016［J］．Modern Preventive Medicine，2018，45（4）：600-602，608.
［10］王黎霞.中国结核病防治工作现状分析［J］．中国公共卫生，2012，28（4）：413-414.http：//www.cnki.com.cn/Article/CJFDTotal-ZGGW201204003.htm.
［11］马海燕，田晓梅，王晓林，等．2011—2014年宁夏肺结核病/艾滋病病毒双重感染现状调查分析［J］．宁夏医学杂志，2015，37（11）：1055-1057．DOI：10.13621/j.1001-5949.2015.11.1055.http：//www.cnki.com.cn/Article/CJFDTotal-NXYX201511044.htm.
［12］顾才宏，王晓林.2006—2010年宁夏结核病防治效果评价［J］．宁夏医学杂志，2013，35（7）：648-649．DOI：10.3969/j.issn.1001-5949.2013.07.034.http：//www.cnki.com.cn/Article/CJFDTotal-NXYX201307041.htm.
［13］马旭，朱海阳，张敏，等．2005—2014年宁夏法定传染病发病趋势及突发公共卫生事件分析［J］．宁夏医科大学学报，2016，38（7）：824-826．DOI：10.16050/j.cnki.issn1674-6309.2016.07.028.http：//www.cnki.com.cn/Article/CJFDTotal-XNXY201607033.htm.
［14］LI X F，WANG L，TAN Y L，et al．Distinct prevalence of drug-resistant tuberculosis in Gansu，China：a retrospective study on drug susceptibility profiles between 2010 and 2014［J］．Microb Drug Resist，2017，23（8）：1025-1031．DOI：10.1089/mdr.2016.0208.
［15］王荣，李晨，杨晨，等．南京市2011—2013年肺结核患者就诊延迟状况及影响因素分析［J］．中华疾病控制杂志，2015，19（8）：854-856．DOI：10.16462/j.cnki.zhjbkz.2015.08.026.
［16］王俊武.2010—2012年安徽省桐城市肺结核流行特征分析［J］．疾病监测，2013，28（9）：740-742.
WANG J W.Epidemiology of pulmonary tuberculosis in Tongcheng，Anhui，2010—2012［J］．Disease Surveillance，2013，28（9）：740-742.
［17］王志江，朱兴国，刘一亚.甘肃省平凉市崆峒区2011—2015年涂阴肺结核流行趋势分析［J］．中国初级卫生保健，2017，31（3）：55-57．DOI：10.3969/j.issn.1001-568X.2017.03.0023.
WANG Z J，ZHU X G，LIU Y Y.An analysis on 2011—2015 prevalence of smear negative pulmonary tuberculosis in Kongtong District of Pingliang City，Gansu Province［J］．Chin Prim Heal Care，2017，31（3）：55-57．DOI：10.3969/j.issn.1001-568X.2017.03.0023.
［18］陈慧娟，陈璞，杨婕，等．2005—2012年贵州省肺结核疫情分析［J］．现代预防医学，2015，42（2）：342-344.　CHEN H J，CHEN P，YANG J，et al．Analysis of tuberculosis epidemics in Guizhou Province between 2005 and 2012［J］．Modern Preventive Medicine，2015，42（2）：342-344.
［19］赵珍，陈鹏，依帕尔?艾海提，等．新疆地区2006—2016年肺结核报告发病和死亡情况分析［J］．中国公共卫生，2018，34（11）：1569-1571.
ZHAO Z，CHEN P，YIPAER A H T，et al．Reported incidence and mortality of pulmonary tuberculosis in Xinjiang region，2006—2016［J］．Chinese Journal of Public Health，2018，34（11）：1569-1571.
［20］马建军，徐长喜，袁燕莉，等．2015年吉林省肺结核流行特征及患者发现情况分析［J］．中国全科医学，2017，20（11）：1360-1363．DOI：10.3969/j.issn.1007-9572.2017.11.016.
MA J J，XU C X，YUAN Y L，et al．Epidemiological characteristics and case finding of pulmonary tuberculosis in Jilin Province in 2015［J］．Chinese General Practice，2017，20（11）：1360-1363．DOI：10.3969/j.issn.1007-9572.2017.11.016.
［21］郑方，沈银忠，吴寰宇，等．2006—2017年上海市常住人口肺结核流行特征分析［J］．上海预防医学，2019，31（2）：150-153．DOI：10.19428/j.cnki.sjpm.2019.18947.
ZHENG F，SHEN Y Z，WU H Y，et al．Epidemiological characteristics of tuberculosis in Shanghai，China，2006—2017［J］．Shanghai Journal of Preventive Medicine，2019，31（2）：150-153．DOI：10.19428/j.cnki.sjpm.2019.18947.
［22］王薇.新疆维吾尔自治区2004—2014年间肺结核病流行状况及趋势分析［D］．兰州：兰州大学，2016.
WANG W.Analysis of the epidemiological characteristics from 2004 to 2014 and prediction of tuberculosis in Xinjiang［D］．Lanzhou：Lanzhou University，2016.
［23］徐东升，左萌萌，王勇.2005—2013年浙江省嘉善县的肺结核流行特征分析及预测研究［J］．现代预防医学，2015，42（19）：3475-3478.
XU D S，ZUO M M，WANG Y.Epidemiological characteristics and prediction of tuberculosis in Jiashan County in Zhejiang Province，2005—2013［J］．Modern Preventive Medicine，2015，42（19）：3475-3478.
［24］NIETO R L M，MEHAFFY C，ISLAM M N，et al．Biochemical characterization of isoniazid-resistant mycobacterium tuberculosis：can the analysis of clonal strains reveal novel targetable pathways?［J］．Mol Cell Proteomics，2018，17（9）：1685-1701．DOI：10.1074/mcp.RA118.000821.

[1]	WU Yixuan, XIAO Liangman, LIU Xin, YAN Ziqi, WANG Yuting, LIN Shumin, ZHUANG Lixing. Analysis of the Disease Burden of Parkinson's Disease in China and Globally from 1990 to 2021 and Prediction of Future Trends [J]. Chinese General Practice, 2026, 29(20): 2895-2902.
[2]	ZHANG Yanjing, ZHOU Chunhua, LI Xiaodong, LIU Yan, WANG Jing, YU Jing. Study on the Clinical Value of a Risk Prediction Model for Venlafaxine Plasma Concentration Exceeding the Safety Threshold [J]. Chinese General Practice, 2026, 29(06): 777-782.
[3]	WANG Xue, YANG Chengming, WANG Ziyun, ZHOU Zhong. Analysis on Prognosis and Influencing Factors in Patients with Post-tuberculosis Bronchiectasis [J]. Chinese General Practice, 2026, 29(05): 606-611.
[4]	CHEN Xueqin, WANG Shihong, LAI Fengxia, ZHANG Jingjing, CHEN Hao, KONG Danli, DING Yuanlin. Study on Trend Analysis and Forecast of Incidence, Disease and Mortality of Chronic Obstructive Pulmonary Disease in China, 1990-2021 [J]. Chinese General Practice, 2026, 29(02): 264-272.
[5]	YANG Qinghui, HU Yingxue, NI Pingwei, LIU Xiao. Analysis of the Incidence and Mortality Trends of Lung Cancer in China from 1990 to 2021 and Prediction for 2035 [J]. Chinese General Practice, 2026, 29(02): 256-263.
[6]	LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong. An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China [J]. Chinese General Practice, 2025, 28(33): 4214-4226.
[7]	WU Yuqing, LIU Zhou, LIAO Yongmei. The Value of Enzyme-linked Immunospot Assay in Identifying Causative Agents in Patients with Hypersensitivity Reactions to Antitubercular Agents [J]. Chinese General Practice, 2025, 28(29): 3684-3687.
[8]	ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659.
[9]	YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263.
[10]	SHANG Zhonghua, JIANG Zhiyue, HUANG Zhaohui, YANG Xing, LIU Haiyan, ZHANG Li. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035 [J]. Chinese General Practice, 2025, 28(26): 3314-3320.
[11]	WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276.
[12]	LUO Xinyu, LIU Jin, CHEN Hailong. Trend Analysis of the Changing Disease Burden of Pancreatitis in China and Worldwide from 1990 to 2021 and Prediction for 2022 to 2031 [J]. Chinese General Practice, 2025, 28(26): 3321-3327.
[13]	LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999.
[14]	National Clinical Research Center for Infectious Diseases Jiangxi Branch, Jiangxi Provincial Key Laboratory of Tuberculosis. Expert Consensus on the Treatment of Pulmonary Tuberculosis Complicated with Chronic Hepatitis B Virus Infection [J]. Chinese General Practice, 2025, 28(24): 2961-2967.
[15]	LI Feifei, ZHOU Peiyao, LU Yaoqin, ZHENG Yanling, ZHANG Liping. Spatiotemporal Distribution Patterns and Influencing Factors of Pulmonary Tuberculosis in Xinjiang: Based on Hierarchical Bayesian Model [J]. Chinese General Practice, 2025, 28(23): 2894-2899.